Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Changing Part D Donut Hole “A Very Expensive Fix,” Daschle Notes

Executive Summary

Changing the "donut hole" in Medicare Part D drug reimbursement and allowing the government to negotiate prices for seniors' medicines will be on the table as the Obama Administration develops its health care proposals

You may also be interested in...

Life In The Donut Hole: OIG Offers Glimpse Into Part D Prescription Habits

In a study of Medicare Part D beneficiaries who entered the coverage gap and had no financial assistance, the HHS Office of Inspector General finds 69 percent decreased the number of drugs purchased.

Daschle’s Prescription for FDA: Leadership, Policy, Money, and Coordination

Restoring confidence in FDA "as the leading science-based regulatory agency in the world" will be a priority for the Department of Health and Human Services, Secretary nominee Tom Daschle told the Senate Health, Education, Labor and Pensions Committee Jan. 8

New Senator Udall Favors Lower Drug Prices, But Not Through Importation

Mark Udall, D-Colo., moves to the Senate with a health care record in the House that includes a "no" vote in 2003 on the Medicare Part D prescription benefit program

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts